Signaling through CD40 enhances cytotoxic T lymphocyte generation by CD8+ T cells from mice bearing large tumors

Cancer Immunology Immunotherapy

Volumn 48, Issue 2-3, 1999, Pages 153-164

  Donepudi, Manjula ^a   Quach, Dong D ^a   Mokyr, Margalit B ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

CD40 ligation; Costimulatory molecules; CTL activity; Tumor bearers

Indexed keywords

CD4 ANTIGEN;

ARTICLE; CELL ACTIVITY; CELL STIMULATION; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; FEMALE; FLOW CYTOMETRY; IMMUNE RESPONSE; LYMPHOCYTOPOIESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD40; ANTIGENS, CD45; ANTIGENS, CD80; ANTIGENS, CD86; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; NEOPLASMS, EXPERIMENTAL; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0032994021     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050560     Document Type: Article

References (38)

1. Bartik MM, Ahn M-C, Baumgartel BA, Hendricks RL, Mokyr MB (1990) Presence of an enlarged pool of MOPC-315 cytotoxic T lymphocyte precursors in the thymuses of mice that eradicated a large MOPC-315 tumor as a consequence of low-dose melphalan therapy. Cancer Immunol Immunother 32:143
2. Bennett SR, Carbone MFR, Karamalis F, Flavell RA, Miller FAP, Heath ER (1998) Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393:478
3. + CTL response. J Exp Med 183:2129
4. Campbell KA, Ovendale PJ, Kennedy MK, Fanslow WC, Reed SG, Maliszewski CR (1996) CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 4:283
5. Caux C, Massacrier C, Vanbervliet B, Dubois B, Kooten Cvan, Durand I, Banchereau J (1994) Activation of human dendritic cells through CD40 cross-linking. J Exp Med 180:1263
6. + T cells to protein antigens in vivo. J Immunol 155:3734
7. Falcon M, Lee J, Patstone G, Yeung B, Sarvetnick N (1998) B lymphocytes are critical antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice. J Immunol 161:1163
8. Gorelik L, Mokyr MB (1995) Low-dose-melphalan-induced up-regulation of type-1 cytokine expression in the s.c. tumor nodule of MOPC-315 tumor bearers and the role of interferon y in the therapeutic outcome. Cancer Immunol Immunother 41:363
9. Gorelik L, Rubin M, Prokhorova A, Mokyr MB (1995) Importance of TNF production for the curative effectiveness of low dose melphalan therapy for mice bearing a large MOPC-315 tumor. J Immunol 154:3941
10. Gorelik L, Bar-Dagan Y, Mokyr MB (1996) Insight into the mechanism(s) through which TNF promotes the generation of T cell-mediated antitumor cytotoxicity by tumor bearer splenic cells. J Immunol 156:4298
11. Grewal IS, Xu J, Flavell RA (1995) Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 378:617
12. Griggs ND, Agersborg SS, Noelle RJ, Ledbetter JA, Linsley PS, Tung KS (1996) The relative contribution of CD28 and gp39 costimulatory pathways in the clonal expansion and pathogenic acquisition of self-reactive T cells. J Exp Med 183:801
13. Hathcock KS, Laszlo G, Dickler H, Bradshaw J, Linsley P, Hodes RJ (1993) Identification of an alternative CTLA-4 ligand costimulatory for T cell activation. Science 262:905
14. Heath AW, Wu WW, Howard MC (1994) Monoclonal antibodies to murine CD40 defines two distinct functional epitopes. Eur J Immunol 24:1828
15. Hirsch R, Gress RE, Pluznik DH, Eckhaus M, Bluestone JA (1989) Effects of in vivo administration of anti-CD3 monoclonal antibody on T cell function in mice. II. In vivo activation of T cells. J Immunol 142:737
16. Hollander GA, Gastigli E, Kulbacki R, Su M, Burakoff SJ, Gutierrez-Ramos J-C, Geha RS (1996) Induction of alloantigen-specific tolerance by B cells from CD40-deficient mice. Proc Natl Acad Sci USA 93:4994
17. Kalinichenko TV, Mokyr MB (1998) Limited importance of CD40/CD40L interaction in the B7-dependent generation of anti-MOPC-315 cytotoxic T lymphocyte activity by tumor bearer splenic cells stimulated in vitro in the presence of tumor necrosis factor. Cancer Immunol Immunother 46:293
18. Kiener PA, Moran-Davis P, Rankin BM, Wahl AF, Aruffo A, Hollenbaugh D (1995) Stimulation of CD40 with purified gp39 induces proinflammatory responses in human monocytes. J Immunol 155:4917
19. Mackey MF, Gunn JR, Ting PP, Kikutani H, Dranoff G, Noelle RJ, Barth RJ (1997) Protective immunity induced by tumor vaccines requires interaction between CD40 and its ligand CD154. Cancer Res 57:2569
20. Mackey MF, Barth RJ, Noelle RJ (1998) The role of CD40/ CD 154 interactions in the priming, differentiation, and effector function of helper and cytotoxic T cells. J Leukoc Biol 63:118
21. Mackey MF, Gunn JR, Maliszewski C, Kikutani H, Noelle RJ, Barth RJ (1998) Dendritic cells require maturation via CD40 to generate protective antitumor immunity. J Immunol 161:2094
22. Mamula MJ, Fatenejad S, Craft J (1994) B cells process and present lupus autoantigens that initiate autoimmune T cell responses. J Immunol 152:1453
23. + cells in the cure of mice bearing a large MOPC-315 tumor by low dose melphalan. J Immunol 151:4838
24. Mokyr MB, Kalinichenko TV, Gorelik L (1997) Potentiation of antitumor CTL responses by GM-CSF involves a B7-dependent mechanism. Cell Immunol 178:152
25. Mokyr MB, Kalinichenko TV, Gorelik L, Bluestone JA (1998) Importance of the B7-2 molecule for low dose melphalan-induced acquisition of tumor-eradicating immunity by mice bearing a large MOPC-315 tumors. J Immunol 160:1866
26. Nakajima A, Kodama T, Morimoto S, Azuma M, Takeda K, Oshima H, Yoshino S, Yagita H, Okumura K (1998) Antitumor effect of CD40 ligand: elicitation of local and systemic antitumor responses by IL-12 and B7. J Immunol 161:1901
27. Ranheim EA, Kipps TJ (1993) Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J Exp Med 177:925
28. Razi-Wolf Z, Freeman GJ, Galvin F, Benacerraf B, Nadler L, Reiser H (1992) Expression and function of the murine B7 antigen, the major costimulatory molecule expressed by peritoneal exudate cells. Proc Natl Acad Sci USA 89:4210
29. Schoenberger SP, Toes RE, van der Voort EIH, Offringa R, Melief CJ (1998) T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393:480
30. Schultze JL, Michalak S, Seamon MJ, Dranoff G, Jung K, Daley J, Delgado JC, Gribben JG, Nadler LM (1997) CD40-activated B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy. J Clin Invest 100:2757
31. Serreze DV, Fleming SA, Chapman HD, Richard SD, Leiter EH, Tisch RM (1998) B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice. J Immunol 161:3912
32. Soong L, Xu JC, Grewal IS, Kima P, Sun J, Longly BJ, Ruddle NH, McMahon-Pratt D, Flavell RA (1996) Disruption of CD40-CD40 ligand interaction results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity 4:263
33. + T-cells in eradication of a large subcutaneous MOPC-315 tumor following low-dose melphalan therapy. Cancer Res 50:7641
34. Unkeless JC (1979) Characterization of monoclonal antibody directed against mouse macrophages and lymphocyte Fc receptors. J Exp Med 150:580
35. Van Kooten C, Banchereau J (1996) CD40-CD40 ligand: a multifunctional receptor-ligand pair. Adv Immunol 61:1
36. Vassalli P (1992) The pathophysiology of tumor necrosis factors. Annu Rev Immunol 10:411
37. Yang Y, Wilson JM (1996) CD40 ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40. Science 273:1862
38. Yellin MJ, Sinning J, Covey RL, Sherman W, Lee JJ, Glicman-Nir E, Sippel KC, Rogers J, Cleary AM, Parker M, Chess L, Lederman S (1994) T lymphocyte T cell-B cell-activating molecule/CD40L molecules induce normal B cells or chronic lymphocytic leukemia B cells to express CD80 (B7/BB-1) and enhance their costimulatory activity. J Immunol 153:666